Abstract
Ocular diseases like cataract, glaucoma, retinoblastoma, diabetic retinopathy, retinal degeneration, retinitis pigmentosa, and choroidal neovascularization are the leading causes of blindness all over the world. Drugs for treating eye diseases are limited in their efficacy due to different ocular barriers. Furthermore, most of the drugs show either poor ocular permeation or rapid clearance from the eyes. The use of colloidal carriers such as nanoparticles, dendrimers, and liposomes has shown the potential to overcome these barriers to the usefulness of a drug. Preclinical and a few clinical studies illustrate that these carrier systems are very useful for delivering wide variety of drugs and genes. These carriers have found applications not only in drug delivery but also in imaging and diagnostics. This chapter focuses on some recent developments in these colloidal systems and discusses how drug delivery to both anterior and posterior eye can be optimized by understanding route of delivery and properties of colloidal systems and their suitability based on drug and disease targeted.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Urtti A (2006) Adv Drug Deliv Rev 58:1131–1135
Rawas-Qalaji M, Williams CA (2012) Curr Eye Res 37:345–356
Xu Q, Kambhampati SP, Kannan RM (2013) Middle East Afr J Ophthalmol 20:26–37
Rowe-Rendleman CL, Durazo SA, Kompella UB, Rittenhouse KD, Di Polo A, Weiner AL, Grossniklaus HE, Naash MI, Lewin AS, Horsager A, Edelhauser HF (2014) Invest Ophthalmol Vis Sci 55:2714–2730
Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE (2009) Adv Drug Deliv Rev 61:428–437
Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R (1994) Science 263:1600–1603
Kompella UB, Amrite AC, Pacha Ravi R, Durazo SA (2013) Prog Retin Eye Res 36:172–198
Zhou HY, Hao JL, Wang S, Zheng Y, Zhang WS (2013) Int J Ophthalmol 6:390–396
Nagarwal RC, Singh PN, Kant S, Maiti P, Pandit JK (2011) Chem Pharm Bull (Tokyo) 59:272–278
Rajendran N, Natrajan R, Kumar R, Selvaraj S (2010) Acyclovir-loaded chitosan nanoparticles for ocular delivery. Asian J Pharm 4:220–226
Aksungur P, Demirbilek M, Denkbas EB, Vandervoort J, Ludwig A, Unlu N (2011) J Control Release 151:286–294
Zambito Y, Di Colo G (2010) Eur J Pharm Biopharm 75:194–199
Mohan RR, Tovey JC, Sharma A, Tandon A (2012) Prog Retin Eye Res 31:43–64
Qazi Y, Stagg B, Singh N, Singh S, Zhang X, Luo L, Simonis J, Kompella UB, Ambati BK (2012) Invest Ophthalmol Vis Sci 53:2837–2844
Pan CK, Durairaj C, Kompella UB, Agwu O, Oliver SC, Quiroz-Mercado H, Mandava N, Olson JL (2011) J Ocul Pharmacol Ther 27:219–224
Koo H, Moon H, Han H, Na JH, Huh MS, Park JH, Woo SJ, Park KH, Kwon IC, Kim K, Kim H (2012) Biomaterials 33:3485–3493
Singh SR, Grossniklaus HE, Kang SJ, Edelhauser HF, Ambati BK, Kompella UB (2009) Gene Ther 16:645–659
Luo L, Zhang X, Hirano Y, Tyagi P, Barabas P, Uehara H, Miya TR, Singh N, Archer B, Qazi Y, Jackman K, Das SK, Olsen T, Chennamaneni SR, Stagg BC, Ahmed F, Emerson L, Zygmunt K, Whitaker R, Mamalis C, Huang W, Gao G, Srinivas SP, Krizaj D, Baffi J, Ambati J, Kompella UB, Ambati BK (2013) ACS Nano 7:3264–3275
Cai X, Conley SM, Nash Z, Fliesler SJ, Cooper MJ, Naash MI (2010) FASEB J 24:1178–1191
Liu M, Frechet JM (1999) Pharm Sci Technol Today 2:393–401
Tomalia DA (2005) Prog Polym Sci 30:294–324
Nanjwade BK, Bechra HM, Derkar GK, Manvi FV, Nanjwade VK (2009) Eur J Pharm Sci 38:185–196
Maraval V, Pyzowski J, Caminade AM, Majoral JP (2003) J Org Chem 68:6043–6046
Wu P, Feldman AK, Nugent AK, Hawker CJ, Scheel A, Voit B, Pyun J, Frechet JM, Sharpless KB, Fokin VV (2004) Angew Chem Int Ed Engl 43:3928–3932
Bravo-Osuna I, Noiray M, Briand E, Woodward AM, Argueso P, Molina Martinez IT, Herrero-Vanrell R, Ponchel G (2012) Pharm Res 29:2329–2340
Vandamme TF, Brobeck L (2005) J Control Release 102:23–38
Wathier M, Jung PJ, Carnahan MA, Kim T, Grinstaff MW (2004) J Am Chem Soc 126:12744–12745
Durairaj C, Kadam RS, Chandler JW, Hutcherson SL, Kompella UB (2010) Invest Ophthalmol Vis Sci 51:5804–5816
Grinstaff MW (2007) Biomaterials 28:5205–5214
Yavuz B, xe; in; Bozda; x11f; Pehlivan, S.; xdc; nl; xfc; Nur; x15f; en (2013) Sci World J 13
Spataro G, Malecaze F, Turrin CO, Soler V, Duhayon C, Elena PP, Majoral JP, Caminade AM (2010) Eur J Med Chem 45:326–334
Shaunak S, Thomas S, Gianasi E, Godwin A, Jones E, Teo I, Mireskandari K, Luthert P, Duncan R, Patterson S, Khaw P, Brocchini S (2004) Nat Biotechnol 22:977–984
Kang SJ, Durairaj C, Kompella UB, O’Brien JM, Grossniklaus HE (2009) Arch Ophthalmol 127:1043–1047
Marano RJ, Toth I, Wimmer N, Brankov M, Rakoczy PE (2005) Gene Ther 12:1544–1550
Duan X, Sheardown H (2006) Biomaterials 27:4608–4617
Duan X, McLaughlin C, Griffith M, Sheardown H (2007) Biomaterials 28:78–88
Sugisaki K, Usui T, Nishiyama N, Jang WD, Yanagi Y, Yamagami S, Amano S, Kataoka K (2008) Invest Ophthalmol Vis Sci 49:894–899
Makky A, Michel JP, Maillard P, Rosilio V (2011) Biochim Biophys Acta 1808:656–666
Nishiyama N, Morimoto Y, Jang WD, Kataoka K (2009) Adv Drug Deliv Rev 61:327–338
Nishiyama N, Stapert HR, Zhang GD, Takasu D, Jiang DL, Nagano T, Aida T, Kataoka K (2003) Bioconjug Chem 14:58–66
Nishiyama N, Iriyama A, Jang WD, Miyata K, Itaka K, Inoue Y, Takahashi H, Yanagi Y, Tamaki Y, Koyama H, Kataoka K (2005) Nat Mater 4:934–941
Bravo-Osuna I, Herrero-Vanrell R, Molina Martinez IT, Giron N, Gomez R, de la Mata F, Guzman Navarro M (2010) Invest Ophthalmol Vis Sci 51:437
Yao W, Sun K, Mu H, Liang N, Liu Y, Yao C, Liang R, Wang A (2010) Drug Dev Ind Pharm 36:1027–1035
Iezzi R, Guru BR, Glybina IV, Mishra MK, Kennedy A, Kannan RM (2012) Biomaterials 33:979–988
Holden CA, Tyagi P, Thakur A, Kadam R, Jadhav G, Kompella UB, Yang H (2012) Nanomedicine 8:776–783
Yang H, Tyagi P, Kadam RS, Holden CA, Kompella UB (2012) ACS Nano 6:7595–7606
Kannan S, Dai H, Navath RS, Balakrishnan B, Jyoti A, Janisse J, Romero R, Kannan RM (2012). Sci Transl Med 4:130ra46
Szoka F Jr, Papahadjopoulos D (1980) Annu Rev Biophys Bioeng 9:467–508
Szoka F Jr, Papahadjopoulos D (1978) Proc Natl Acad Sci U S A 75:4194–4198
Damji KF, Noel LP, Peterson RG, Ma PE, Clarke WN, Gilberg S, Crouch ER Jr, Williams PB (1998) Can J Ophthalmol 33:308–313
Frucht-Perry J, Assil KK, Ziegler E, Douglas H, Brown SI, Schanzlin DJ, Weinreb RN (1992) Cornea 11:393–397
Scott LJ, Goa KL (2000) Drugs Aging 16:139–46; discussion 147–8
Masuda I, Matsuo T, Yasuda T, Matsuo N (1996) Invest Ophthalmol Vis Sci 37:1914–1920
Matsuo T, Masuda I, Yasuda T, Matsuo N (1996) Biochem Biophys Res Commun 219:947–950
Van der Veen G, Broersma L, Dijkstra CD, Van Rooijen N, Van Rij G, Van der Gaag R (1994) Invest Ophthalmol Vis Sci 35:3505–3515
Van der Veen G, Broersma L, Van Rooijen N, Van Rij G, Van der Gaag R (1998) Curr Eye Res 17:1018–1026
Lin HH, Ko SM, Hsu LR, Tsai YH (1996) J Pharm Pharmacol 48:801–805
Pleyer U, Lutz S, Jusko WJ, Nguyen KD, Narawane M, Ruckert D, Mondino BJ, Lee VH, Nguyen K (1993) Invest Ophthalmol Vis Sci 34:2737–2742
McCalden TA, Levy M (1990) Experientia 46:713–715
Kawakami S, Yamamura K, Mukai T, Nishida K, Nakamura J, Sakaeda T, Nakashima M, Sasaki H (2001) J Pharm Pharmacol 53:1157–1161
Frangie JP (1995) Clin Pharmacokinet 29:130–138
BenEzra D, Maftzir G (1990) Arch Ophthalmol 108:584–587
Fiscella RG, Gieser J, Phillpotts B, Gilmartin C, Labib S, Cwik MJ, Solomon MJ, Shapiro MJ (1998) Retina 18:339–342
Schulman J, Peyman GA, Fiscella R, Greenberg D, Horton MB, de Miranda P (1986) Br J Ophthalmol 70:138–140
Alghadyan AA, Peyman GA, Khoobehi B, Milner S, Liu KR (1988) Int Ophthalmol 12:109–112
Alghadyan AA, Peyman GA, Khoobehi B, Liu KR (1988) Int Ophthalmol 12:105–107
Liu KR, Peyman GA, Khoobehi B, Alkan H, Fiscella R (1987) Ophthalmology 94:1155–1159
Khoobehi B, Peyman GA, Niesman MR, Oncel M (1989) Ophthalmology 96:905–912
Aggarwal D, Kaur IP (2005) Int J Pharm 290:155–159
Aggarwal D, Pal D, Mitra AK, Kaur IP (2007) Int J Pharm 338:21–26
Li Q, Li Z, Zeng W, Ge S, Lu H, Wu C, Ge L, Liang D, Xu Y (2014) Eur J Pharm Sci 62:115–123
Han S, Shen JQ, Gan Y, Geng HM, Zhang XX, Zhu CL, Gan L (2010) Acta Pharmacol Sin 31:990–998
Gan L, Han S, Shen J, Zhu J, Zhu C, Zhang X, Gan Y (2010) Int J Pharm 396:179–187
Klang SH, Siganos CS, Benita S, Frucht-Pery J (1999) J Control Release 57:19–27
Gan L, Gan Y, Zhu C, Zhang X, Zhu J (2009) Int J Pharm 365:143–149
Klang S, Abdulrazik M, Benita S (2000) Pharm Dev Technol 5:521–532
Ayalasomayajula SP, Kompella UB (2005) Eur J Pharmacol 511:191–198
Kompella UB, Bandi N, Ayalasomayajula SP (2003) Invest Ophthalmol Vis Sci 44:1192–1201
Chaplot SP, Rupenthal ID (2013) J Pharm Pharmacol 66:542–556
Gomes dos Santos AL, Bochot A l, Doyle A, Tsapis N, Siepmann J, Siepmann F, Schmaler J, Besnard M, Behar-Cohen F, Fattal E (2006) J Control Release 112:369–381
Carrasquillo KG, Ricker JA, Rigas IK, Miller JW, Gragoudas ES, Adamis AP (2003) Invest Ophthalmol Vis Sci 44:290–299
Gomes dos Santos A, Bochot A l, Tsapis N, Artzner F, Bejjani R, Thillaye-Goldenberg B, de Kozak Y, Fattal E, Behar-Cohen F (2006) Pharm Res 23:770–781
Johnson LN, Cashman SM, Read SP, Kumar-Singh R (2010) Vision Res 50:686–697
Hagigit T, Abdulrazik M, Valamanesh F, Behar-Cohen F, Benita S (2012) J Control Release 160:225–231
Jiang M, Gan L, Zhu C, Dong Y, Liu J, Gan Y (2012) Biomaterials 33:7621–7630
Bloquel C, Bejjani R, Bigey P, Bedioui F, Doat M, BenEzra D, Scherman D, Behar-Cohen F (2006) FASEB J 20:389–391
Peeters L, Lentacker I, Vandenbroucke R, Lucas B, Demeester J, Sanders N, De Smedt S (2008) Pharm Res 25:2657–2665
Ormonde S, Chou C-Y, Goold L, Petsoglou C, Al-Taie R, Sherwin T, McGhee CJ, Green C (2012) J Membr Biol 245:381–388
Deva N, Zhang J, Green C, Danesh-Meyer H (2012) Inflammation 35:1276–1286
Grupcheva CN, Laux WT, Rupenthal ID, McGhee J, McGhee CNJ, Green CR (2012) Invest Ophthalmol Vis Sci 53:1130–1138
Rupenthal ID, Alany RG, Green CR (2011) Mol Pharm 8:2282–2290
Thrimawithana TR, Young SA, Bunt CR, Green CR, Alany RG (2011) Eur J Pharm Sci 44:399–409
Bhisitkul RB, Robinson GS, Moulton RS, Claffey KP, Gragoudas ES, Miller JW (2005) Arch Ophthalmol 123:214–219
Mo Y, Barnett ME, Takemoto D, Davidson H, Kompella UB (2007) Mol Vis 13:746–757
Park K, Chen Y, Hu Y, Mayo AS, Kompella UB, Longeras R, Ma JX (2009) Diabetes 58:1902–1913
Amrite AC, Kompella UB (2005) J Pharm Pharmacol 57:1555–1563
Jin J, Zhou KK, Park K, Hu Y, Xu X, Zheng Z, Tyagi P, Kompella UB, Ma JX (2011) Invest Ophthalmol Vis Sci 52:6230–6237
Tyagi P, Kadam RS, Kompella UB (2012) PLoS One 7, e48188
Gaudana R, Ananthula HK, Parenky A, Mitra AK. AAPS J 12:348–360
Cheruvu NP, Amrite AC, Kompella UB (2008) Invest Ophthalmol Vis Sci 49:333–341
Amrite AC, Edelhauser HF, Singh SR, Kompella UB (2008) Mol Vis 14:150–160
Cheruvu NP, Amrite AC, Kompella UB (2009) Pharm Res 26:404–414
Kompella UB, Sundaram S, Raghava S, Escobar ER (2006) Mol Vis 12:1185–1198
Eljarrat-Binstock E, Orucov F, Aldouby Y, Frucht-Pery J, Domb AJ (2008) J Control Release 126:156–161
Kim H, Robinson SB, Csaky KG (2009) Pharm Res 26:329–337
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Gupta, D. (2016). Colloidal Carriers in Ophthalmic Drug Delivery. In: Pathak, Y., Sutariya, V., Hirani, A. (eds) Nano-Biomaterials For Ophthalmic Drug Delivery. Springer, Cham. https://doi.org/10.1007/978-3-319-29346-2_15
Download citation
DOI: https://doi.org/10.1007/978-3-319-29346-2_15
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-29344-8
Online ISBN: 978-3-319-29346-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)